|
Market Closed -
Euronext Paris
09:25:00 12/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 38.40 EUR | -0.90% |
|
-1.92% | -10.80% |
| 05/08 | Neurones posts strong growth |  |
| 05/08 | NEURONES Raises Earnings Guidance for the Full Year 2026 | CI |
Company Valuation: NEURONES
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 920.3 | 950.8 | 1,062 | 1,067 | 1,047 | 924.8 | - | - |
| Change | - | 3.32% | 11.69% | 0.47% | -1.89% | -11.64% | - | - |
| Enterprise Value (EV) 1 | 655.7 | 679 | 771.5 | 747.4 | 710.1 | 593.4 | 561.1 | 523.9 |
| Change | - | 3.56% | 13.62% | -3.13% | -4.99% | -16.43% | -5.44% | -6.63% |
| P/E | 24.5x | 21.6x | 21.6x | 20.3x | 20.1x | 16.6x | 15x | 13.7x |
| PBR | 2.95x | 2.87x | 3x | 2.82x | 2.62x | 2.24x | 2.1x | 1.97x |
| PEG | - | 1.2x | 1.9x | 3.17x | -21.71x | 1.89x | 1.4x | 1.37x |
| Capitalization / Revenue | 1.59x | 1.43x | 1.43x | 1.32x | 1.22x | 1.02x | 0.97x | 0.93x |
| EV / Revenue | 1.13x | 1.02x | 1.04x | 0.92x | 0.83x | 0.66x | 0.59x | 0.53x |
| EV / EBITDA | 8.6x | 7.59x | 8.33x | 7.82x | 7.46x | 5.84x | 5.05x | 4.34x |
| EV / EBIT | 10.6x | 9.31x | 10.2x | 9.59x | 9.39x | 7.29x | 6.22x | 5.28x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 1 | 1 | 1.2 | 1.3 | 1.4 | 1.5 | 1.6 | 1.7 |
| Rate of return | 2.63% | 2.55% | 2.74% | 2.96% | 3.25% | 3.87% | 4.13% | 4.39% |
| EPS 2 | 1.55 | 1.82 | 2.03 | 2.16 | 2.14 | 2.328 | 2.576 | 2.833 |
| Distribution rate | 64.5% | 54.9% | 59.1% | 60.2% | 65.4% | 64.4% | 62.1% | 60% |
| Net sales 1 | 579.9 | 665.4 | 741.2 | 810.4 | 857.2 | 904.3 | 949.6 | 992.3 |
| EBITDA 1 | 76.28 | 89.44 | 92.61 | 95.58 | 95.14 | 101.6 | 111.1 | 120.7 |
| EBIT 1 | 61.6 | 72.9 | 75.9 | 77.9 | 75.6 | 81.39 | 90.21 | 99.23 |
| Net income 1 | 37.7 | 44.3 | 49.4 | 52.5 | 52.1 | 56.76 | 62.8 | 69.06 |
| Net Debt 1 | -264.6 | -271.8 | -290.4 | -319.5 | -336.6 | -331.5 | -363.8 | -401 |
| Reference price 2 | 38.00 | 39.25 | 43.75 | 43.95 | 43.05 | 38.75 | 38.75 | 38.75 |
| Nbr of stocks (in thousands) | 24,218 | 24,224 | 24,272 | 24,274 | 24,313 | 23,867 | - | - |
| Announcement Date | 09/02/22 | 08/02/23 | 06/03/24 | 05/03/25 | 11/03/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.64x | 0.66x | 5.84x | 3.87% | 106.72Cr | |
| 23.66x | 3.81x | 13.3x | 2.83% | 22TCr | |
| -117.13x | 18.65x | 107.67x | -.--% | 12TCr | |
| 13.33x | 1.47x | 7.73x | 3.61% | 11TCr | |
| 15.84x | 2.9x | 10.95x | 5.19% | 9.28TCr | |
| 20.42x | 5.36x | 13.16x | 2.79% | 6.15TCr | |
| 15.59x | 2.28x | 9.68x | 5.01% | 5.06TCr | |
| 21.73x | 1.58x | 10.05x | 0.87% | 4.07TCr | |
| 20.98x | 1.72x | 10.51x | 1.4% | 4.05TCr | |
| 18.6x | 2.44x | 11.46x | 4.68% | 3.87TCr | |
| Average | 4.97x | 4.09x | 20.03x | 3.02% | 7.76TCr | |
| Weighted average by Cap. | -1.03x | 5.31x | 25.64x | 2.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- NRO Stock
- Valuation NEURONES
Select your edition
All financial news and data tailored to specific country editions
